NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ||
Founding Date | Founding Date 2006 | Founding Date 1948 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | |
Employees | Employees 91 | Employees 650 |
Financial | ||
Revenue (est.) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods £11.1m (FY, 2025) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit £38.2m (FY, 2025) | Gross profit £510.3m (FY, 2019) |
Net income | Net income £7m (FY, 2025) | Net income £88.3m (FY, 2019) |